Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00747045 · ClinicalTrials.gov registry record · NA

Lung Protective Ventilation in Pulmonary Thromboendarterectomy (PTE) Patients

A NA study of Acute Lung Injury and Chronic Thromboembolic Pulmonary Hypertension, sponsored by University of California, San Diego.

Completed
Registry status
NA
Development phase
128
Enrollment target
1
Study location

NCT00747045 is a NA study of Acute Lung Injury and Chronic Thromboembolic Pulmonary Hypertension that has completed, run by University of California, San Diego. The registered enrollment target is 128 participants, above the 113-participant average among 10 other Acute Lung Injury trials with a reported enrollment target (13% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00747045, a NA study of Acute Lung Injury and Chronic Thromboembolic Pulmonary Hypertension, has completed, sponsored by University of California, San Diego.

COMPLETED
Registry status
NA
Development phase
128 participants
Enrollment target
1
Study location

Study Summary

Chronic thromboembolic pulmonary hypertension (CTEPH) is caused by unresolved thromboemboli in the pulmonary arteries, which lead to pulmonary hypertension and, left untreated, right heart failure. This disease can be potentially cured by performing a pulmonary thromboendarterectomy (PTE) to remove the blood clots. The surgery is not without risk and the most worrisome complication is the development of a form of acute lung injury called reperfusion lung injury, which occurs in about 40 percent of patients. The landmark publication of the ARDSNET study demonstrated that a low tidal volume strategy of mechanical ventilation, decreased morbidity and mortality in patients who had acute respiratory distress syndrome (ARDS). Since then there have been some studies examining the role of a low tidal volume strategy in all patients who are mechanically ventilated. Some studies have demonstrated a decreased incidence of acute lung injury while others have failed to do the same. In patients at high risk for developing acute lung injury, such as patients undergoing PTE, there may be a benefit to using low tidal volumes to reduce the incidence of reperfusion lung injury. To assess the efficacy of a low tidal volume ventilation strategy in patients undergoing PTE, 134 patients will be randomized at the time of surgery to either low tidal volumes (6ml/kg of ideal body weight), or standard tidal volumes (10ml/kg of ideal body weight). Patients will be followed clinically to assess for the development of reperfusion lung injury. This will be defined as the development of hypoxemia (PaO2/FiO2 ratio less than 300) and chest infiltrates in the area of reperfused lung with no other identifiable etiology within the first 72 hours of surgery. Patients will also be assessed for other factors known to contribute to acute lung injury including: plateau pressures, peak inspiratory pressures, fluid balance, and number of transfusions received. Secondary endpoints of the study will be: time

Interventions

  • OTHER Ventilation Strategy

Study Locations (1)

California

  • UCSD - Thornton Hospital - La Jolla

Trial Details

FieldValue
Enrollment Target 128 participants
Start Date 2008-08
Est. Completion 2011-03
Phase NA

Sponsor

University of California, San Diego

775 total trials

What the Registry Record Tells You About NCT00747045

The ClinicalTrials.gov registry entry for NCT00747045 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 113-participant average among 10 other Acute Lung Injury trials with a reported enrollment target (13% higher). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Acute Lung Injury appearing as the primary indexed condition, and to 1 intervention - of which Ventilation Strategy is the first listed.

NCT00747045 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT00747045 about?

NCT00747045 is a clinical study titled "Lung Protective Ventilation in Pulmonary Thromboendarterectomy (PTE) Patients". Chronic thromboembolic pulmonary hypertension (CTEPH) is caused by unresolved thromboemboli in the pulmonary arteries, which lead to pulmonary hypertension and, left untreated, right heart failure. This disease can be potentially cured by performing a pulmonary thromboendarterectomy (PTE) to remove ...

What is the current status of trial NCT00747045?

This trial is currently completed. It is a NA study. The enrollment target is 128 participants. The study started on 2008-08. Estimated completion is 2011-03.

What conditions does trial NCT00747045 study?

This clinical trial studies the following conditions: Acute Lung Injury, Chronic Thromboembolic Pulmonary Hypertension.

What interventions are being tested in trial NCT00747045?

The interventions under investigation include: Ventilation Strategy (OTHER).

Who is sponsoring clinical trial NCT00747045?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00747045 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acute Lung Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.